European Journal of Cancer

Aims & Scope

The European Journal of Cancer (including EJC Supplements), is an international comprehensive oncology journal that publishes original research, editorial comments, review articles and news on experimental oncology, clinical oncology (medical, paediatric, radiation, surgical), translational oncology, and on cancer epidemiology and prevention.

The Journal now has online submission for authors.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	7.1
2024	7.60

SJR (SCImago Journal Rank)

Year	Value
2024	2.691

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	256

Journal Rank

Year	Value
2024	861

Journal Citation Indicator

Year	Value
2024	8867

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

  Citation: 22934

  Authors: E.A., P., J., L.H., D., R., J., S., S., M., L., L., L., R., D., J.

• Radiomics: Extracting more information from medical images using advanced feature analysis

  Citation: 4599

  Authors: Philippe, Emmanuel, Ralph, Sara, Ruud G.P.M., Patrick, Catharina M.L., Robert, Ronald, André, Hugo J.W.L.

• Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012

  Citation: 3910

  Authors: J., E., J., S., J.W.W., H., D., F.

• A survey of telomerase activity in human cancer

  Citation: 2171

  Authors: J.W., S.

• Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018

  Citation: 1914

  Authors: J., M., I., T., G., M., A., O., F.

• Immune-related adverse events with immune checkpoint blockade: a comprehensive review

  Citation: 1743

  Authors: J.M., C., S., M., F., S., A., A., R., A., C., A., V., A., J.P., N., E., N., C., C., C., J.C., A., O.

• Estimates of cancer incidence and mortality in Europe in 2008

  Citation: 1661

  Authors: J., D.M., E.

• EGFR and cancer prognosis

  Citation: 1603

  Authors: R.I, J.M.W, M.E

• RECIST 1.1—Update and clarification: From the RECIST committee

  Citation: 1481

  Authors: Lawrence H., Saskia, Elisabeth, Robert, Stephen, Sumithra, Lalitha, Jan, Alice, Janet, Wendy, F. Stephen, Otto S., Erich P., Nancy, Yan, Patrick, Jedd D., Lesley

• Cancer burden in the year 2000. The global picture

  Citation: 1436

  Authors: D.M, F.I, S.S

---